Skip to main content

Advertisement

SpringerLink
Log in

Does the role of non-coding RNA FAM131B-AS2 in glioblastoma go beyond the ATR pathway? A correspondence

  • Correspondence
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

(a statement on how any datasets used can be accessed): Not applicable.

References

  1. Wang S, Qi Y, Zhao R, Pan Z, Li B, Qiu W, Zhao S, Guo X, Ni S, Li G, Xue H Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress. Neuro-oncology 2024 Jan 29:noae014

  2. Jalloh M, Kankam SB, Osifala O (2024) Could the combination of immunotherapy and target therapy be a potential double edge sword for glioblastoma treatment? A correspondence. Neurosurg Rev 47(1):1–2

    Article  Google Scholar 

  3. Shafizadeh M, Farzaneh F, Kankam SB, Jangholi E, Shafizadeh Y, Khoshnevisan A (2023) Effects of postoperative intravenous cyclosporine treatment on the survival and functional performance status of patients with glioblastoma: a randomized, triple-blinded, placebo-controlled clinical trial. World Neurosurg 176:e548–e556

    Article  PubMed  Google Scholar 

  4. Jalloh M, Kankam SB Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence. J Neuro-Oncology 2024 Feb 23:1–3

  5. Korovina I, Vehlow A, Temme A, Cordes N (2023) Targeting integrin α2 as potential strategy for radiochemosensitization of glioblastoma. Neurooncology 25(4):648–661

    CAS  Google Scholar 

  6. Kyritsis AP, Bondy ML, Rao JS, Sioka C (2010) Inherited predisposition to glioma. Neurooncology 12(1):104–113

    CAS  Google Scholar 

  7. Omuro A, Brandes AA, Carpentier AF, Idbaih A, Reardon DA, Cloughesy T, Sumrall A, Baehring J, van den Bent M, Bähr O, Lombardi G (2023) Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial. Neurooncology 25(1):123–134

    CAS  Google Scholar 

Download references

Funding

(details of any funding received): Not applicable.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

    Mohamed Jalloh & Samuel Berchi Kankam

  2. Harvard T.H Chan School of Public Health, Harvard University, Boston, USA

    Oluwafeyisola Osifala, Samuel Berchi Kankam & Olayinka Fakorede

Authors
  1. Mohamed Jalloh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oluwafeyisola Osifala
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samuel Berchi Kankam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olayinka Fakorede
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.B.K: Conceptualization, Manuscript drafting, Critical revision of the manuscript, Supervision; M.J: Manuscript drafting, Critical revision of the manuscript; O.O: Manuscript drafting, Critical revision of the manuscript; O.F: Manuscript drafting, Critical revision of the manuscript.

Corresponding author

Correspondence to Samuel Berchi Kankam.

Ethics declarations

Ethical approval

(Applicable for both human and/ or animal studies. Ethical committees, Internal Review Boards and guidelines followed must be named. When applicable, additional headings with statements on consent to participate and consent to publish are also required): Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jalloh, M., Osifala, O., Kankam, S.B. et al. Does the role of non-coding RNA FAM131B-AS2 in glioblastoma go beyond the ATR pathway? A correspondence. Neurosurg Rev 47, 192 (2024). https://doi.org/10.1007/s10143-024-02428-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10143-024-02428-7

Search

Navigation